Ambri gets new business software
Wednesday, 01 May, 2002
Ambri has adopted new business software and services from Frontstep, to help it to take its new clinical diagnostic system from prototype to full-scale manufacture.
Ambri's CEO and managing director, Joe Shaw, said Frontstep's solution will provide a flexible and highly scalable platform for the company as it moves closer toward establishing commercial manufacturing operations and its North American expansion.
Frontsteps' SyteLine provides a business management platform that will allow Ambri to satisfy the US Food and Drug Administration regulations.
"We will not become a global organisation without people and suppliers who are dedicated to joining with us to achieve this objective," said Shaw.
ADHD may be linked with an increased risk of dementia
An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...
Placebos appear to reduce PMS symptoms
Women affected by premenstrual syndrome (PMS) appear to experience less intense and debilitating...
Medicinal cannabis linked to long-term health benefits
As scientists find a way to improve the effectiveness of CBD, a separate study shows that...
